Physician profile
William Shutze
NPI 1598728032
$53,278.64
in general payments reported to CMS, 2019-2025
30 companies · $835 in 2025
The $835 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $36K · 2020: $4,879 · 2021: $6,306 · 2022: $1,328 · 2023: $2,139 · 2024: $1,497 · 2025: $835.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,585 · Travel and Lodging: $886.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,584.98 |
| Travel and Lodging | $886.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $36,959.66 | 2019-2020 | |
| Medtronic, INC. | $5,635.56 | 2021-2024 | Endurant Iis, In.Pact Admiral |
| Silk Road Medical, INC. | $5,557.95 | 2019-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| W. L. Gore & Associates, INC. | $1,536.72 | 2022-2025 | Gore Tag Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Viabahn Endoprosthesis With Heparin |
| Shape Memory Medical INC. | $891.53 | 2023-2025 | Impede Embolization Plug |
| Penumbra, INC. | $744.71 | 2021-2023 | Ruby Coil |
| Bolton Medical INC | $688.38 | 2022-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System, Thoraflex Hybrid |
| Tactile Systems Technology INC | $186.23 | 2023-2024 | Entre Plus, Flexitouch Plus |
| Ekos Corporation | $177.67 | 2019 | |
| Cook Medical LLC | $136.81 | 2025 | Zenith Spiral-Z |
| Heartflow, INC. | $110.37 | 2019 | |
| Surmodics, INC. | $103.84 | 2023 | Pounce Venous Thrombectomy System, Pounce Thrombectomy, Sublime Radial Access Guide Sheath |
| Abbott Laboratories | $80.76 | 2021 | |
| Boston Scientific Corporation | $74.62 | 2023 | |
| Cvrx, INC. | $44.95 | 2024-2025 | Barostim Neo System |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $43.83 | 2019-2021 | |
| Inari Medical, INC. | $36.61 | 2022 | |
| Endologix LLC | $34.25 | 2024 | Torus Stent Graft System, Endocross Device |
| Acell, INC. | $32.12 | 2020 | |
| Lemaitre Vascular, INC. | $30.39 | 2023 | Artegraft Vascular Graft |
| Terumo Medical Corporation | $28.54 | 2023 | Glidewire, Metacross Otw, Heartrail |
| Viz.Ai, INC. | $28.28 | 2022 | |
| Axogen | $25.18 | 2024 | Axoguard Nerve Protector, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Shockwave Medical, INC | $21.18 | 2019 | |
| Angiodynamics, INC. | $19.42 | 2023 | Auryon Laser System 100-120 Vac |
| Philips North America LLC | $19.23 | 2019-2021 | |
| Smith+Nephew, INC. | $17.19 | 2019 | |
| Integra Lifesciences Corporation | $12.66 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$19,230.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Shutze listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.